1969年款 鲍尔温动态阶段 III GT 克尔维特
在60年代中期,鲍德温的雪佛兰经销商和运动性能部门,即开发一种雪佛兰的调谐器的部门,联合起来提供定制的汽车。在1971年,联邦政府则因为惩罚他们的汽车安全性能不足,而勒令停业。这款1969年款克尔维特是一辆采用工厂427引擎的汽车,并且采用III期的套装设计,从而保证了在11秒的时间内跑出四分之一英里的成绩。但修复版最令人印象深刻的部分则可能是车身本身,因为它拥有裸露的大灯,谢尔比式的排风口,以及庞蒂亚克的火鸟式尾灯。
在60年代中期,鲍德温的雪佛兰经销商和运动性能部门,即开发一种雪佛兰的调谐器的部门,联合起来提供定制的汽车。在1971年,联邦政府则因为惩罚他们的汽车安全性能不足,而勒令停业。这款1969年款克尔维特是一辆采用工厂427引擎的汽车,并且采用III期的套装设计,从而保证了在11秒的时间内跑出四分之一英里的成绩。但修复版最令人印象深刻的部分则可能是车身本身,因为它拥有裸露的大灯,谢尔比式的排风口,以及庞蒂亚克的火鸟式尾灯。
SOREL expands the Horizon collection by carrying the rugged DNA of its iconic Caribou boot across three silhouettes built for changing terrain and seasons. The Callsign Horizon Low GTX brings the concept closest to a sneaker, pairing waterproof GORE-TEX® construction with lightweight Livelyfoam cushioning and a Vibram XS Trek Evo outsole for everyday traction. Moving higher, the Daystorm Horizon GTX combines full-grain leather, GORE-TEX® waterproofing, and a rugged Vibram® lug outsole for everything from wet city streets to the trail. At the top of the lineup, the Caribou Horizon GTX modernizes SOREL's winter icon with 200 grams of insulation, seam-sealed leather, a GORE-TEX® membrane, and Caribou-inspired Vibram traction for snow, slush, and cold-weather exploration.
Presented by SOREL.
Arbor makes physician-prescribed GLP-1 weight loss treatment more accessible with transparent pricing that stays put, even as doses change. Plans start at $99/month for compounded semaglutide and $149/month for compounded tirzepatide, with no insurance, hidden fees, or membership costs required. The telehealth platform connects patients with licensed U.S. clinicians through a simple online assessment, with eligible prescriptions shipped free and each subscription covering medication, consultations, dose adjustments, and ongoing support. Board-certified physicians, dietitian-led nutrition guidance, and a 12-month money-back guarantee for eligible members round out a program designed to make medically supervised weight management simpler and more affordable.
Presented by Arbor.
Arbor is a technology platform; medical evaluations are conducted by independent licensed providers who determine whether treatment is appropriate. Compounded medications are not reviewed by the FDA for safety or effectiveness. Consultation requirements vary by state.